title: Editorial Commentary: Pediatric Acute Kidney Injury: Is the Addition of Gentamicin Worth the Risk?
authors.affiliation: Department of Pediatrics, Division of General Pediatrics and Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee.
authors.forename: Sara
authors.initials: S
authors.lastname: Van Driest
authors.affiliation: Children's Mercy Hospitals and Clinics, Department of Pediatrics, Divisions of Pediatric Infectious Diseases and Clinical Pharmacology, University of Missouri-Kansas City.
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Goldman
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D016470:Bacteremia / Q000188:drug therapy*; D013293:Enterococcus faecalis; D005839:Gentamicins / Q000009:adverse effects*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents; D005839:Gentamicins
keywords: gentamicin; pediatric acute kidney injury